Synthesis of insulin-like growth factor II (IGF-II) in fetal rat tissues: translation of IGF-II ribonucleic acid and processing of pre-pro-IGF-II

• Published in: Endocrinology (Philadelphia) Vol. 122; no. 2; p. 709
• Main Authors: Romanus, J A, Yang, Y W, Adams, S O, Sofair, A N, Tseng, L Y, Nissley, S P, Rechler, M M
• Format: Journal Article
• Language: English
• Published: United States 01.02.1988
• Subjects: Animals; Insulin-Like Growth Factor II - biosynthesis; Insulin-Like Growth Factor II - genetics; Liver - embryology; Liver - metabolism; Lung - metabolism; Molecular Weight; Protein Biosynthesis; Protein Precursors - genetics; Rats; Rats, Inbred Strains; RNA - metabolism; RNA Splicing; RNA, Messenger - metabolism; Somatomedins - biosynthesis; Somatomedins - genetics
• ISSN: 0013-7227
• DOI: 10.1210/endo-122-2-709

The single insulin-like growth factor II (IGF-II) gene is transcribed into multiple RNA species in most fetal and neonatal rat tissues. For IGF-II to serve as a local growth factor in fetal tissues, IGF-II RNA must be translated into pre-pro-rat (r) IGF-II, and the biosynthetic precursor processed to smaller biologically active forms. IGF-II RNA extracted from fetal rat liver, muscle, intestine, lung, and stomach, from rat placenta, and from fetal or neonatal mouse liver and lung directed the synthesis of 22,000 mol wt pre-pro-IGF-II in a reticulocyte lysate cell-free translation system. A biosynthetic precursor of this size had been observed previously in translation of RNA from BRL-3A rat liver cells and is predicted by the nucleotide sequence of cDNA clones encoding rIGF-II. Consistent with the developmental pattern of expression of IGF-II RNA observed in hybridization studies, RNA from adult rat liver, muscle, and intestine did not direct the synthesis of pre-pro-rIGF-II. To determine whether the IGF-II biosynthetic precursor was processed to smaller biologically active IGF-II, term fetal rat tissues were extracted with acid-ethanol, the extracts were fractionated by acid gel filtration, and the IGF pools were examined in a RIA specific for IGF-II. Levels of 1-2 micrograms/g were observed in liver, limb, lung, intestine, and brain; lower levels were observed in heart and kidney. In general, the levels of immunoreactive IGF-II corresponded to the levels of IGF-II mRNA. These results suggest that IGF-II mRNA is translated, and pre-pro-IGF-II processed to mature IGF-II in different fetal rat tissues. In contrast to IGF-I, in which alternative RNA splicing generates possible precursor molecules containing different COOH-terminal propeptide segments, we find no evidence for an IGF-II precursor in rat tissues other than 22,000 mol wt pre-pro-rIGF-II.